Capstan Medical TMVR Study: FIH
NCT: NCT06600191 · RECRUITING
NCT IDNCT06600191
StatusRECRUITING
Start Date2025-02-24
Completion2031-12
SponsorCapstan Medical (INDUSTRY)
First posted
Last updated
Brief Summary
This study is a prospective, multi-center, non-randomized first in human study to evaluate the safety and feasibility of the Capstan Medical TMVR System for intervention in adults with moderate-severe or greater mitral regurgitation who are not surgical candidates.
Frequently Asked Questions
What is Capstan Medical TMVR Study: FIH?
Capstan Medical TMVR Study: FIH is a clinical trial registered under NCT06600191. Current status: RECRUITING.
What is the status of NCT06600191?
The current status of NCT06600191 (Capstan Medical TMVR Study: FIH) is: RECRUITING.
When did Capstan Medical TMVR Study: FIH start?
Capstan Medical TMVR Study: FIH started on 2025-02-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.